<DOC>
	<DOCNO>NCT00168948</DOCNO>
	<brief_summary>- intermittent preventive treatment SP child evaluate efficacy safety drug combination child northern Ghana</brief_summary>
	<brief_title>Intermittent Antimalaria Treatment With SP African Children</brief_title>
	<detailed_description>- Sulfadoxine pyrimethamine long use malaria prevention treatment . In study , follow suggestion WHO , drug use intermittent treatment . - It test approach reduces number malaria attack ameliorate severity disease - It also determine anemia due malaria , prevalent northern Ghana , may reduce - Moreover , interaction red cell polymorphism HbS , HbC , alpha-thalassemia glucose-6-phosphate dehydrogenase deficiency SP examine</detailed_description>
	<mesh_term>Malaria</mesh_term>
	<mesh_term>Pyrimethamine</mesh_term>
	<criteria>informed consent parent guardian concomitant serious disease age &gt; 2 month serious allergy hypersensitivity sulfonamide pyrimethamine severe hepatic renal dysfunction serious breach study protocol</criteria>
	<gender>All</gender>
	<minimum_age>2 Months</minimum_age>
	<maximum_age>4 Months</maximum_age>
	<verification_date>February 2003</verification_date>
	<keyword>Intermittent preventive treatment</keyword>
	<keyword>IPTi</keyword>
	<keyword>Malaria control</keyword>
	<keyword>Ghana</keyword>
</DOC>